- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Covid-19 Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Covid-19 Diagnostic size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Covid-19 Diagnostic market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Covid-19 Diagnostic market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Immunoassay
Genomic and WGS Role
rRT-PCR
Market segment by Application, can be divided into
Hospital
Laboratory
Market segment by players, this report covers
Abbott Diagnostics
Accelerate Diagnostics
Ador Diagnostics
Akkoni Biosystems
Alveo Technologies
Applied BioCode
Aus Diagnostics
BD Diagnostics
Biocartis
BioFire Diagnostics
bioMérieux
Bio-Rad Laboratories
Bosch Healthcare Solutions GmbH
Cepheid
Co-Diagnostics
Cue Health
Curetis
Diagenode Diagnostics
Diascopic
Diasorin
Expedeon
Fusion Genomics.
GenePOC Diagnostics
GenMark Dx
Hologic
Immunexpress
Inflammatix
Invetech
Janssen Diagnostics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Covid-19 Diagnostic
1.2 Classification of Covid-19 Diagnostic by Type
1.2.1 Overview: Global Covid-19 Diagnostic Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Covid-19 Diagnostic Revenue Market Share by Type in 2020
1.2.3 Immunoassay
1.2.4 Genomic and WGS Role
1.2.5 rRT-PCR
1.3 Global Covid-19 Diagnostic Market by Application
1.3.1 Overview: Global Covid-19 Diagnostic Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Laboratory
1.4 Global Covid-19 Diagnostic Market Size & Forecast
1.5 Global Covid-19 Diagnostic Market Size and Forecast by Region
1.5.1 Global Covid-19 Diagnostic Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Covid-19 Diagnostic Market Size by Region, (2016-2021)
1.5.3 North America Covid-19 Diagnostic Market Size and Prospect (2016-2026)
1.5.4 Europe Covid-19 Diagnostic Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Covid-19 Diagnostic Market Size and Prospect (2016-2026)
1.5.6 South America Covid-19 Diagnostic Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Covid-19 Diagnostic Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Covid-19 Diagnostic Market Drivers
1.6.2 Covid-19 Diagnostic Market Restraints
1.6.3 Covid-19 Diagnostic Trends Analysis
2 Company Profiles
2.1 Abbott Diagnostics
2.1.1 Abbott Diagnostics Details
2.1.2 Abbott Diagnostics Major Business
2.1.3 Abbott Diagnostics Covid-19 Diagnostic Product and Solutions
2.1.4 Abbott Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Diagnostics Recent Developments and Future Plans
2.2 Accelerate Diagnostics
2.2.1 Accelerate Diagnostics Details
2.2.2 Accelerate Diagnostics Major Business
2.2.3 Accelerate Diagnostics Covid-19 Diagnostic Product and Solutions
2.2.4 Accelerate Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Accelerate Diagnostics Recent Developments and Future Plans
2.3 Ador Diagnostics
2.3.1 Ador Diagnostics Details
2.3.2 Ador Diagnostics Major Business
2.3.3 Ador Diagnostics Covid-19 Diagnostic Product and Solutions
2.3.4 Ador Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Ador Diagnostics Recent Developments and Future Plans
2.4 Akkoni Biosystems
2.4.1 Akkoni Biosystems Details
2.4.2 Akkoni Biosystems Major Business
2.4.3 Akkoni Biosystems Covid-19 Diagnostic Product and Solutions
2.4.4 Akkoni Biosystems Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Akkoni Biosystems Recent Developments and Future Plans
2.5 Alveo Technologies
2.5.1 Alveo Technologies Details
2.5.2 Alveo Technologies Major Business
2.5.3 Alveo Technologies Covid-19 Diagnostic Product and Solutions
2.5.4 Alveo Technologies Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Alveo Technologies Recent Developments and Future Plans
2.6 Applied BioCode
2.6.1 Applied BioCode Details
2.6.2 Applied BioCode Major Business
2.6.3 Applied BioCode Covid-19 Diagnostic Product and Solutions
2.6.4 Applied BioCode Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Applied BioCode Recent Developments and Future Plans
2.7 Aus Diagnostics
2.7.1 Aus Diagnostics Details
2.7.2 Aus Diagnostics Major Business
2.7.3 Aus Diagnostics Covid-19 Diagnostic Product and Solutions
2.7.4 Aus Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Aus Diagnostics Recent Developments and Future Plans
2.8 BD Diagnostics
2.8.1 BD Diagnostics Details
2.8.2 BD Diagnostics Major Business
2.8.3 BD Diagnostics Covid-19 Diagnostic Product and Solutions
2.8.4 BD Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 BD Diagnostics Recent Developments and Future Plans
2.9 Biocartis
2.9.1 Biocartis Details
2.9.2 Biocartis Major Business
2.9.3 Biocartis Covid-19 Diagnostic Product and Solutions
2.9.4 Biocartis Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Biocartis Recent Developments and Future Plans
2.10 BioFire Diagnostics
2.10.1 BioFire Diagnostics Details
2.10.2 BioFire Diagnostics Major Business
2.10.3 BioFire Diagnostics Covid-19 Diagnostic Product and Solutions
2.10.4 BioFire Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 BioFire Diagnostics Recent Developments and Future Plans
2.11 bioMérieux
2.11.1 bioMérieux Details
2.11.2 bioMérieux Major Business
2.11.3 bioMérieux Covid-19 Diagnostic Product and Solutions
2.11.4 bioMérieux Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 bioMérieux Recent Developments and Future Plans
2.12 Bio-Rad Laboratories
2.12.1 Bio-Rad Laboratories Details
2.12.2 Bio-Rad Laboratories Major Business
2.12.3 Bio-Rad Laboratories Covid-19 Diagnostic Product and Solutions
2.12.4 Bio-Rad Laboratories Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.13 Bosch Healthcare Solutions GmbH
2.13.1 Bosch Healthcare Solutions GmbH Details
2.13.2 Bosch Healthcare Solutions GmbH Major Business
2.13.3 Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Product and Solutions
2.13.4 Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Bosch Healthcare Solutions GmbH Recent Developments and Future Plans
2.14 Cepheid
2.14.1 Cepheid Details
2.14.2 Cepheid Major Business
2.14.3 Cepheid Covid-19 Diagnostic Product and Solutions
2.14.4 Cepheid Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Cepheid Recent Developments and Future Plans
2.15 Co-Diagnostics
2.15.1 Co-Diagnostics Details
2.15.2 Co-Diagnostics Major Business
2.15.3 Co-Diagnostics Covid-19 Diagnostic Product and Solutions
2.15.4 Co-Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Co-Diagnostics Recent Developments and Future Plans
2.16 Cue Health
2.16.1 Cue Health Details
2.16.2 Cue Health Major Business
2.16.3 Cue Health Covid-19 Diagnostic Product and Solutions
2.16.4 Cue Health Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Cue Health Recent Developments and Future Plans
2.17 Curetis
2.17.1 Curetis Details
2.17.2 Curetis Major Business
2.17.3 Curetis Covid-19 Diagnostic Product and Solutions
2.17.4 Curetis Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Curetis Recent Developments and Future Plans
2.18 Diagenode Diagnostics
2.18.1 Diagenode Diagnostics Details
2.18.2 Diagenode Diagnostics Major Business
2.18.3 Diagenode Diagnostics Covid-19 Diagnostic Product and Solutions
2.18.4 Diagenode Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Diagenode Diagnostics Recent Developments and Future Plans
2.19 Diascopic
2.19.1 Diascopic Details
2.19.2 Diascopic Major Business
2.19.3 Diascopic Covid-19 Diagnostic Product and Solutions
2.19.4 Diascopic Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Diascopic Recent Developments and Future Plans
2.20 Diasorin
2.20.1 Diasorin Details
2.20.2 Diasorin Major Business
2.20.3 Diasorin Covid-19 Diagnostic Product and Solutions
2.20.4 Diasorin Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 Diasorin Recent Developments and Future Plans
2.21 Expedeon
2.21.1 Expedeon Details
2.21.2 Expedeon Major Business
2.21.3 Expedeon Covid-19 Diagnostic Product and Solutions
2.21.4 Expedeon Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.21.5 Expedeon Recent Developments and Future Plans
2.22 Fusion Genomics.
2.22.1 Fusion Genomics. Details
2.22.2 Fusion Genomics. Major Business
2.22.3 Fusion Genomics. Covid-19 Diagnostic Product and Solutions
2.22.4 Fusion Genomics. Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.22.5 Fusion Genomics. Recent Developments and Future Plans
2.23 GenePOC Diagnostics
2.23.1 GenePOC Diagnostics Details
2.23.2 GenePOC Diagnostics Major Business
2.23.3 GenePOC Diagnostics Covid-19 Diagnostic Product and Solutions
2.23.4 GenePOC Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.23.5 GenePOC Diagnostics Recent Developments and Future Plans
2.24 GenMark Dx
2.24.1 GenMark Dx Details
2.24.2 GenMark Dx Major Business
2.24.3 GenMark Dx Covid-19 Diagnostic Product and Solutions
2.24.4 GenMark Dx Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.24.5 GenMark Dx Recent Developments and Future Plans
2.25 Hologic
2.25.1 Hologic Details
2.25.2 Hologic Major Business
2.25.3 Hologic Covid-19 Diagnostic Product and Solutions
2.25.4 Hologic Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.25.5 Hologic Recent Developments and Future Plans
2.26 Immunexpress
2.26.1 Immunexpress Details
2.26.2 Immunexpress Major Business
2.26.3 Immunexpress Covid-19 Diagnostic Product and Solutions
2.26.4 Immunexpress Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.26.5 Immunexpress Recent Developments and Future Plans
2.27 Inflammatix
2.27.1 Inflammatix Details
2.27.2 Inflammatix Major Business
2.27.3 Inflammatix Covid-19 Diagnostic Product and Solutions
2.27.4 Inflammatix Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.27.5 Inflammatix Recent Developments and Future Plans
2.28 Invetech
2.28.1 Invetech Details
2.28.2 Invetech Major Business
2.28.3 Invetech Covid-19 Diagnostic Product and Solutions
2.28.4 Invetech Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.28.5 Invetech Recent Developments and Future Plans
2.29 Janssen Diagnostics
2.29.1 Janssen Diagnostics Details
2.29.2 Janssen Diagnostics Major Business
2.29.3 Janssen Diagnostics Covid-19 Diagnostic Product and Solutions
2.29.4 Janssen Diagnostics Covid-19 Diagnostic Revenue, Gross Margin and Market Share (2019-2021)
2.29.5 Janssen Diagnostics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Covid-19 Diagnostic Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Covid-19 Diagnostic Players Market Share
3.2.2 Top 10 Covid-19 Diagnostic Players Market Share
3.2.3 Market Competition Trend
3.3 Covid-19 Diagnostic Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Covid-19 Diagnostic Revenue and Market Share by Type (2016-2021)
4.2 Global Covid-19 Diagnostic Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Covid-19 Diagnostic Revenue Market Share by Application (2016-2021)
5.2 Covid-19 Diagnostic Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Covid-19 Diagnostic Revenue by Type (2016-2026)
6.2 North America Covid-19 Diagnostic Revenue by Application (2016-2026)
6.3 North America Covid-19 Diagnostic Market Size by Country
6.3.1 North America Covid-19 Diagnostic Revenue by Country (2016-2026)
6.3.2 United States Covid-19 Diagnostic Market Size and Forecast (2016-2026)
6.3.3 Canada Covid-19 Diagnostic Market Size and Forecast (2016-2026)
6.3.4 Mexico Covid-19 Diagnostic Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Covid-19 Diagnostic Revenue by Type (2016-2026)
7.2 Europe Covid-19 Diagnostic Revenue by Application (2016-2026)
7.3 Europe Covid-19 Diagnostic Market Size by Country
7.3.1 Europe Covid-19 Diagnostic Revenue by Country (2016-2026)
7.3.2 Germany Covid-19 Diagnostic Market Size and Forecast (2016-2026)
7.3.3 France Covid-19 Diagnostic Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Covid-19 Diagnostic Market Size and Forecast (2016-2026)
7.3.5 Russia Covid-19 Diagnostic Market Size and Forecast (2016-2026)
7.3.6 Italy Covid-19 Diagnostic Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Covid-19 Diagnostic Revenue by Type (2016-2026)
8.2 Asia-Pacific Covid-19 Diagnostic Revenue by Application (2016-2026)
8.3 Asia-Pacific Covid-19 Diagnostic Market Size by Region
8.3.1 Asia-Pacific Covid-19 Diagnostic Revenue by Region (2016-2026)
8.3.2 China Covid-19 Diagnostic Market Size and Forecast (2016-2026)
8.3.3 Japan Covid-19 Diagnostic Market Size and Forecast (2016-2026)
8.3.4 South Korea Covid-19 Diagnostic Market Size and Forecast (2016-2026)
8.3.5 India Covid-19 Diagnostic Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Covid-19 Diagnostic Market Size and Forecast (2016-2026)
8.3.7 Australia Covid-19 Diagnostic Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Covid-19 Diagnostic Revenue by Type (2016-2026)
9.2 South America Covid-19 Diagnostic Revenue by Application (2016-2026)
9.3 South America Covid-19 Diagnostic Market Size by Country
9.3.1 South America Covid-19 Diagnostic Revenue by Country (2016-2026)
9.3.2 Brazil Covid-19 Diagnostic Market Size and Forecast (2016-2026)
9.3.3 Argentina Covid-19 Diagnostic Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Covid-19 Diagnostic Revenue by Type (2016-2026)
10.2 Middle East & Africa Covid-19 Diagnostic Revenue by Application (2016-2026)
10.3 Middle East & Africa Covid-19 Diagnostic Market Size by Country
10.3.1 Middle East & Africa Covid-19 Diagnostic Revenue by Country (2016-2026)
10.3.2 Turkey Covid-19 Diagnostic Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Covid-19 Diagnostic Market Size and Forecast (2016-2026)
10.3.4 UAE Covid-19 Diagnostic Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Covid-19 Diagnostic Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Covid-19 Diagnostic Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Covid-19 Diagnostic Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Covid-19 Diagnostic Revenue (USD Million) by Region (2016-2021)
Table 5. Global Covid-19 Diagnostic Revenue Market Share by Region (2021-2026)
Table 6. Abbott Diagnostics Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Diagnostics Major Business
Table 8. Abbott Diagnostics Covid-19 Diagnostic Product and Solutions
Table 9. Abbott Diagnostics Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Accelerate Diagnostics Corporate Information, Head Office, and Major Competitors
Table 11. Accelerate Diagnostics Major Business
Table 12. Accelerate Diagnostics Covid-19 Diagnostic Product and Solutions
Table 13. Accelerate Diagnostics Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Ador Diagnostics Corporate Information, Head Office, and Major Competitors
Table 15. Ador Diagnostics Major Business
Table 16. Ador Diagnostics Covid-19 Diagnostic Product and Solutions
Table 17. Ador Diagnostics Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Akkoni Biosystems Corporate Information, Head Office, and Major Competitors
Table 19. Akkoni Biosystems Major Business
Table 20. Akkoni Biosystems Covid-19 Diagnostic Product and Solutions
Table 21. Akkoni Biosystems Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Alveo Technologies Corporate Information, Head Office, and Major Competitors
Table 23. Alveo Technologies Major Business
Table 24. Alveo Technologies Covid-19 Diagnostic Product and Solutions
Table 25. Alveo Technologies Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Applied BioCode Corporate Information, Head Office, and Major Competitors
Table 27. Applied BioCode Major Business
Table 28. Applied BioCode Covid-19 Diagnostic Product and Solutions
Table 29. Applied BioCode Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Aus Diagnostics Corporate Information, Head Office, and Major Competitors
Table 31. Aus Diagnostics Major Business
Table 32. Aus Diagnostics Covid-19 Diagnostic Product and Solutions
Table 33. Aus Diagnostics Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. BD Diagnostics Corporate Information, Head Office, and Major Competitors
Table 35. BD Diagnostics Major Business
Table 36. BD Diagnostics Covid-19 Diagnostic Product and Solutions
Table 37. BD Diagnostics Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Biocartis Corporate Information, Head Office, and Major Competitors
Table 39. Biocartis Major Business
Table 40. Biocartis Covid-19 Diagnostic Product and Solutions
Table 41. Biocartis Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. BioFire Diagnostics Corporate Information, Head Office, and Major Competitors
Table 43. BioFire Diagnostics Major Business
Table 44. BioFire Diagnostics Covid-19 Diagnostic Product and Solutions
Table 45. BioFire Diagnostics Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. bioMérieux Corporate Information, Head Office, and Major Competitors
Table 47. bioMérieux Major Business
Table 48. bioMérieux Covid-19 Diagnostic Product and Solutions
Table 49. bioMérieux Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 51. Bio-Rad Laboratories Major Business
Table 52. Bio-Rad Laboratories Covid-19 Diagnostic Product and Solutions
Table 53. Bio-Rad Laboratories Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Bosch Healthcare Solutions GmbH Corporate Information, Head Office, and Major Competitors
Table 55. Bosch Healthcare Solutions GmbH Major Business
Table 56. Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Product and Solutions
Table 57. Bosch Healthcare Solutions GmbH Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Cepheid Corporate Information, Head Office, and Major Competitors
Table 59. Cepheid Major Business
Table 60. Cepheid Covid-19 Diagnostic Product and Solutions
Table 61. Cepheid Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Co-Diagnostics Corporate Information, Head Office, and Major Competitors
Table 63. Co-Diagnostics Major Business
Table 64. Co-Diagnostics Covid-19 Diagnostic Product and Solutions
Table 65. Co-Diagnostics Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Cue Health Corporate Information, Head Office, and Major Competitors
Table 67. Cue Health Major Business
Table 68. Cue Health Covid-19 Diagnostic Product and Solutions
Table 69. Cue Health Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Curetis Corporate Information, Head Office, and Major Competitors
Table 71. Curetis Major Business
Table 72. Curetis Covid-19 Diagnostic Product and Solutions
Table 73. Curetis Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Diagenode Diagnostics Corporate Information, Head Office, and Major Competitors
Table 75. Diagenode Diagnostics Major Business
Table 76. Diagenode Diagnostics Covid-19 Diagnostic Product and Solutions
Table 77. Diagenode Diagnostics Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Diascopic Corporate Information, Head Office, and Major Competitors
Table 79. Diascopic Major Business
Table 80. Diascopic Covid-19 Diagnostic Product and Solutions
Table 81. Diascopic Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Diasorin Corporate Information, Head Office, and Major Competitors
Table 83. Diasorin Major Business
Table 84. Diasorin Covid-19 Diagnostic Product and Solutions
Table 85. Diasorin Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Expedeon Corporate Information, Head Office, and Major Competitors
Table 87. Expedeon Major Business
Table 88. Expedeon Covid-19 Diagnostic Product and Solutions
Table 89. Expedeon Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 90. Fusion Genomics. Corporate Information, Head Office, and Major Competitors
Table 91. Fusion Genomics. Major Business
Table 92. Fusion Genomics. Covid-19 Diagnostic Product and Solutions
Table 93. Fusion Genomics. Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 94. GenePOC Diagnostics Corporate Information, Head Office, and Major Competitors
Table 95. GenePOC Diagnostics Major Business
Table 96. GenePOC Diagnostics Covid-19 Diagnostic Product and Solutions
Table 97. GenePOC Diagnostics Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 98. GenMark Dx Corporate Information, Head Office, and Major Competitors
Table 99. GenMark Dx Major Business
Table 100. GenMark Dx Covid-19 Diagnostic Product and Solutions
Table 101. GenMark Dx Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 102. Hologic Corporate Information, Head Office, and Major Competitors
Table 103. Hologic Major Business
Table 104. Hologic Covid-19 Diagnostic Product and Solutions
Table 105. Hologic Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 106. Immunexpress Corporate Information, Head Office, and Major Competitors
Table 107. Immunexpress Major Business
Table 108. Immunexpress Covid-19 Diagnostic Product and Solutions
Table 109. Immunexpress Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 110. Inflammatix Corporate Information, Head Office, and Major Competitors
Table 111. Inflammatix Major Business
Table 112. Inflammatix Covid-19 Diagnostic Product and Solutions
Table 113. Inflammatix Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 114. Invetech Corporate Information, Head Office, and Major Competitors
Table 115. Invetech Major Business
Table 116. Invetech Covid-19 Diagnostic Product and Solutions
Table 117. Invetech Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 118. Janssen Diagnostics Corporate Information, Head Office, and Major Competitors
Table 119. Janssen Diagnostics Major Business
Table 120. Janssen Diagnostics Covid-19 Diagnostic Product and Solutions
Table 121. Janssen Diagnostics Covid-19 Diagnostic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 122. Global Covid-19 Diagnostic Revenue (USD Million) by Players (2019-2021)
Table 123. Global Covid-19 Diagnostic Revenue Share by Players (2019-2021)
Table 124. Breakdown of Covid-19 Diagnostic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 125. Covid-19 Diagnostic Players Head Office, Products and Services Provided
Table 126. Covid-19 Diagnostic Mergers & Acquisitions in the Past Five Years
Table 127. Covid-19 Diagnostic New Entrants and Expansion Plans
Table 128. Global Covid-19 Diagnostic Revenue (USD Million) by Type (2016-2021)
Table 129. Global Covid-19 Diagnostic Revenue Share by Type (2016-2021)
Table 130. Global Covid-19 Diagnostic Revenue Forecast by Type (2021-2026)
Table 131. Global Covid-19 Diagnostic Revenue by Application (2016-2021)
Table 132. Global Covid-19 Diagnostic Revenue Forecast by Application (2021-2026)
Table 133. North America Covid-19 Diagnostic Revenue by Type (2016-2021) & (USD Million)
Table 134. North America Covid-19 Diagnostic Revenue by Type (2021-2026) & (USD Million)
Table 135. North America Covid-19 Diagnostic Revenue by Application (2016-2021) & (USD Million)
Table 136. North America Covid-19 Diagnostic Revenue by Application (2021-2026) & (USD Million)
Table 137. North America Covid-19 Diagnostic Revenue by Country (2016-2021) & (USD Million)
Table 138. North America Covid-19 Diagnostic Revenue by Country (2021-2026) & (USD Million)
Table 139. Europe Covid-19 Diagnostic Revenue by Type (2016-2021) & (USD Million)
Table 140. Europe Covid-19 Diagnostic Revenue by Type (2021-2026) & (USD Million)
Table 141. Europe Covid-19 Diagnostic Revenue by Application (2016-2021) & (USD Million)
Table 142. Europe Covid-19 Diagnostic Revenue by Application (2021-2026) & (USD Million)
Table 143. Europe Covid-19 Diagnostic Revenue by Country (2016-2021) & (USD Million)
Table 144. Europe Covid-19 Diagnostic Revenue by Country (2021-2026) & (USD Million)
Table 145. Asia-Pacific Covid-19 Diagnostic Revenue by Type (2016-2021) & (USD Million)
Table 146. Asia-Pacific Covid-19 Diagnostic Revenue by Type (2021-2026) & (USD Million)
Table 147. Asia-Pacific Covid-19 Diagnostic Revenue by Application (2016-2021) & (USD Million)
Table 148. Asia-Pacific Covid-19 Diagnostic Revenue by Application (2021-2026) & (USD Million)
Table 149. Asia-Pacific Covid-19 Diagnostic Revenue by Region (2016-2021) & (USD Million)
Table 150. Asia-Pacific Covid-19 Diagnostic Revenue by Region (2021-2026) & (USD Million)
Table 151. South America Covid-19 Diagnostic Revenue by Type (2016-2021) & (USD Million)
Table 152. South America Covid-19 Diagnostic Revenue by Type (2021-2026) & (USD Million)
Table 153. South America Covid-19 Diagnostic Revenue by Application (2016-2021) & (USD Million)
Table 154. South America Covid-19 Diagnostic Revenue by Application (2021-2026) & (USD Million)
Table 155. South America Covid-19 Diagnostic Revenue by Country (2016-2021) & (USD Million)
Table 156. South America Covid-19 Diagnostic Revenue by Country (2021-2026) & (USD Million)
Table 157. Middle East & Africa Covid-19 Diagnostic Revenue by Type (2016-2021) & (USD Million)
Table 158. Middle East & Africa Covid-19 Diagnostic Revenue by Type (2021-2026) & (USD Million)
Table 159. Middle East & Africa Covid-19 Diagnostic Revenue by Application (2016-2021) & (USD Million)
Table 160. Middle East & Africa Covid-19 Diagnostic Revenue by Application (2021-2026) & (USD Million)
Table 161. Middle East & Africa Covid-19 Diagnostic Revenue by Country (2016-2021) & (USD Million)
Table 162. Middle East & Africa Covid-19 Diagnostic Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Covid-19 Diagnostic Picture
Figure 2. Global Covid-19 Diagnostic Revenue Market Share by Type in 2020
Figure 3. Immunoassay
Figure 4. Genomic and WGS Role
Figure 5. rRT-PCR
Figure 6. Covid-19 Diagnostic Revenue Market Share by Application in 2020
Figure 7. Hospital Picture
Figure 8. Laboratory Picture
Figure 9. Global Covid-19 Diagnostic Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Covid-19 Diagnostic Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Covid-19 Diagnostic Revenue Market Share by Region (2016-2026)
Figure 12. Global Covid-19 Diagnostic Revenue Market Share by Region in 2020
Figure 13. North America Covid-19 Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Covid-19 Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Covid-19 Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Covid-19 Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Covid-19 Diagnostic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Covid-19 Diagnostic Market Drivers
Figure 19. Covid-19 Diagnostic Market Restraints
Figure 20. Covid-19 Diagnostic Market Trends
Figure 21. Abbott Diagnostics Recent Developments and Future Plans
Figure 22. Accelerate Diagnostics Recent Developments and Future Plans
Figure 23. Ador Diagnostics Recent Developments and Future Plans
Figure 24. Akkoni Biosystems Recent Developments and Future Plans
Figure 25. Alveo Technologies Recent Developments and Future Plans
Figure 26. Applied BioCode Recent Developments and Future Plans
Figure 27. Aus Diagnostics Recent Developments and Future Plans
Figure 28. BD Diagnostics Recent Developments and Future Plans
Figure 29. Biocartis Recent Developments and Future Plans
Figure 30. BioFire Diagnostics Recent Developments and Future Plans
Figure 31. bioMérieux Recent Developments and Future Plans
Figure 32. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 33. Bosch Healthcare Solutions GmbH Recent Developments and Future Plans
Figure 34. Cepheid Recent Developments and Future Plans
Figure 35. Co-Diagnostics Recent Developments and Future Plans
Figure 36. Cue Health Recent Developments and Future Plans
Figure 37. Curetis Recent Developments and Future Plans
Figure 38. Diagenode Diagnostics Recent Developments and Future Plans
Figure 39. Diascopic Recent Developments and Future Plans
Figure 40. Diasorin Recent Developments and Future Plans
Figure 41. Expedeon Recent Developments and Future Plans
Figure 42. Fusion Genomics. Recent Developments and Future Plans
Figure 43. GenePOC Diagnostics Recent Developments and Future Plans
Figure 44. GenMark Dx Recent Developments and Future Plans
Figure 45. Hologic Recent Developments and Future Plans
Figure 46. Immunexpress Recent Developments and Future Plans
Figure 47. Inflammatix Recent Developments and Future Plans
Figure 48. Invetech Recent Developments and Future Plans
Figure 49. Janssen Diagnostics Recent Developments and Future Plans
Figure 50. Global Covid-19 Diagnostic Revenue Share by Players in 2020
Figure 51. Covid-19 Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 52. Global Top 3 Players Covid-19 Diagnostic Revenue Market Share in 2020
Figure 53. Global Top 10 Players Covid-19 Diagnostic Revenue Market Share in 2020
Figure 54. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 55. Global Covid-19 Diagnostic Revenue Share by Type in 2020
Figure 56. Global Covid-19 Diagnostic Market Share Forecast by Type (2021-2026)
Figure 57. Global Covid-19 Diagnostic Revenue Share by Application in 2020
Figure 58. Global Covid-19 Diagnostic Market Share Forecast by Application (2021-2026)
Figure 59. North America Covid-19 Diagnostic Sales Market Share by Type (2016-2026)
Figure 60. North America Covid-19 Diagnostic Sales Market Share by Application (2016-2026)
Figure 61. North America Covid-19 Diagnostic Revenue Market Share by Country (2016-2026)
Figure 62. United States Covid-19 Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Canada Covid-19 Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Mexico Covid-19 Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Europe Covid-19 Diagnostic Sales Market Share by Type (2016-2026)
Figure 66. Europe Covid-19 Diagnostic Sales Market Share by Application (2016-2026)
Figure 67. Europe Covid-19 Diagnostic Revenue Market Share by Country (2016-2026)
Figure 68. Germany Covid-19 Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. France Covid-19 Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. United Kingdom Covid-19 Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Russia Covid-19 Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Italy Covid-19 Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Asia-Pacific Covid-19 Diagnostic Sales Market Share by Type (2016-2026)
Figure 74. Asia-Pacific Covid-19 Diagnostic Sales Market Share by Application (2016-2026)
Figure 75. Asia-Pacific Covid-19 Diagnostic Revenue Market Share by Region (2016-2026)
Figure 76. China Covid-19 Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Japan Covid-19 Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Korea Covid-19 Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. India Covid-19 Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Southeast Asia Covid-19 Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Australia Covid-19 Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. South America Covid-19 Diagnostic Sales Market Share by Type (2016-2026)
Figure 83. South America Covid-19 Diagnostic Sales Market Share by Application (2016-2026)
Figure 84. South America Covid-19 Diagnostic Revenue Market Share by Country (2016-2026)
Figure 85. Brazil Covid-19 Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. Argentina Covid-19 Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 87. Middle East and Africa Covid-19 Diagnostic Sales Market Share by Type (2016-2026)
Figure 88. Middle East and Africa Covid-19 Diagnostic Sales Market Share by Application (2016-2026)
Figure 89. Middle East and Africa Covid-19 Diagnostic Revenue Market Share by Country (2016-2026)
Figure 90. Turkey Covid-19 Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 91. Saudi Arabia Covid-19 Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 92. UAE Covid-19 Diagnostic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 93. Methodology
Figure 94. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
